A small study reported that patients with COVID-19-associated AKI and high levels of [TIMP-2] × [IGFBP7] were more likely to progress to renal replacement therapy than those with AKI but with low [TIMP-2] × [IGFBP7] [16]. The gene discussed is IGFBP7; the disease is acute kidney injury.